Publication:
SEOM clinical guidelines on cardiovascular toxicity (2018).

Simple item page
dc.contributor.authorVirizuela, J A
dc.contributor.authorGarcía, A M
dc.contributor.authorde Las Peñas, R
dc.contributor.authorSantaballa, A
dc.contributor.authorAndrés, R
dc.contributor.authorBeato, C
dc.contributor.authorde la Cruz, S
dc.contributor.authorGavilá, J
dc.contributor.authorGonzález-Santiago, S
dc.contributor.authorFernández, T L
dc.date.accessioned2023-01-25T10:27:56Z
dc.date.available2023-01-25T10:27:56Z
dc.date.issued2019-01-09
dc.description.abstractOne of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM's ongoing commitment to progressing and improving supportive care for cancer patients.
dc.identifier.doi10.1007/s12094-018-02017-3
dc.identifier.essn1699-3055
dc.identifier.pmcPMC6339681
dc.identifier.pmid30627982
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339681/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s12094-018-02017-3.pdf
dc.identifier.urihttp://hdl.handle.net/10668/13408
dc.issue.number1
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationHospital Universitario Virgen Macarena
dc.page.number94-105
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCancer
dc.subjectCardiotoxicity
dc.subjectChemotherapy
dc.subjectEarly detection
dc.subjectRisk assessment
dc.subject.meshAntineoplastic Agents
dc.subject.meshCardiotonic Agents
dc.subject.meshCardiotoxicity
dc.subject.meshCardiovascular Diseases
dc.subject.meshClinical Trials as Topic
dc.subject.meshDisease Management
dc.subject.meshHumans
dc.subject.meshNeoplasms
dc.subject.meshPractice Guidelines as Topic
dc.subject.meshPrognosis
dc.subject.meshSocieties, Medical
dc.titleSEOM clinical guidelines on cardiovascular toxicity (2018).
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number21
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC6339681.pdf
Size:
2.69 MB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía